The U.S. FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent Influenza disease.

The FDA has approved a new flu vaccine nasal spray for at-home use. While this self-administered version won't be available for this year's flu season, interest in nasal spray products is growing.

Most respiratory viruses, like the flu and COVID-19, enter the body through the nose. When an infected person exhales, sneezes, coughs, or even laughs, they release droplets containing the virus, which others can inhale. These pathogens attach to the nasal lining, replicate, and are further spread.

Gaithersburg, Maryland-based MedImmune has received the FDA’s approval of its FluMist nasal spray flu vaccine, meaning no physician needed.

FluMist contains a weakened form of live flu virus strains and is sprayed into the nose. “The nasal spray is a live vaccine so it's only indicated to give to healthy individuals who don't have any immunocompromising condition,” Edler said. FluMist is recommended for anyone between the ages of two and 49.

The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.

The wait for a flu shot at your doctor's office or pharmacy may soon be a thing of the past. The U.S. Food and Drug Administration has approved FluMist nasal spray as the first influenza vaccine for self-administration at home.

The Food and Drug Administration (FDA) has approved the first-ever influenza vaccine that can be administered at home. It’s a nasal spray vaccine called FluMist, and it’s been